Investor alert: class action lawsuit filed on behalf of sana biotechnology, inc. (sana) investors – holzer & holzer, llc encourages investors with significant losses to contact the firm

Atlanta, march 24, 2025 (globe newswire) -- a shareholder class action lawsuit has been filed against sana biotechnology, inc. (“sana” or the “company”) (nasdaq: sana). the lawsuit alleges that defendants made false and/or misleading statements and/or failed to disclose material facts regarding sana's business, operations, and prospects, including allegations that: (i) sana was at significant risk of having insufficient funds to maintain its current operations and advance one or more of its product candidates; (ii) sc291 in oncology, sc379, and sg299 were less promising than defendants had led investors to believe; (iii) in order to preserve cash and advance its more promising product candidates, sana was likely to decrease funding for and/or discontinue sc291 in oncology, sc379, and sg299, as well as significantly reduce its headcount; and (iv) accordingly, defendants overstated sana's financial capacity to maintain its current operations and advance its existing product candidates.
SANA Ratings Summary
SANA Quant Ranking